Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Trading up to the 19th...
If we prevail at ITC (i.e. Gildea's non-infringement is reversed and domestic market is affirmed) do we expect the dormant NDoC cases to be resurrected? If so, when?
Same question if there is no change in the ITC rulings.
Share
New Message
Please login to post a reply